Drug Shortage Report for TIMOLOL MALEATE-EX

Last updated on 2024-12-10 History
Report ID 227853
Drug Identification Number 02242275
Brand name TIMOLOL MALEATE-EX
Common or Proper name TIMOLOL MALEATE-EX
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.25%
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-05-13
Estimated end date 2025-03-21
Actual end date
Shortage status Actual shortage
Updated date 2024-12-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-12-10 French Compare
v16 2024-12-10 English Compare
v15 2024-09-30 French Compare
v14 2024-09-30 English Compare
v13 2024-09-16 French Compare
v12 2024-09-16 English Compare
v11 2024-07-29 French Compare
v10 2024-07-29 English Compare
v9 2024-07-02 French Compare
v8 2024-07-02 English Compare
v7 2024-06-25 French Compare
v6 2024-06-25 English Compare
v5 2024-06-12 French Compare
v4 2024-06-12 English Compare
v3 2024-05-14 English Compare
v2 2024-05-13 French Compare
v1 2024-05-13 English Compare

Showing 1 to 17 of 17